Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | JAZZ | EXEL | ||
| Company | Intra-Cellular Ther | Jazz Pharma Plc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 244.47 | 55.92 | ||
| High | 131.98 | 246.07 | 55.97 | ||
| Low | 131.63 | 241.82 | 54.85 | ||
| Latest | 131.87 | 244.17 | 55.53 | ||
| Change | -0.05 | +0.70 | -0.32 | ||
| % Change | -0.04% | +0.29% | -0.57% | ||
| Volume | 16,062,900 | 861,400 | 3,143,300 | ||
| 20-Day Average Volume | 2,474,570 | 888,750 | 2,768,315 | ||
| Previous Close | 131.92 | 243.47 | 55.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 232.57 | 53.18 | ||
| 20-Day Raw Stochastic | 86.25% | 92.50% | 87.43% | ||
| 20-Day Relative Strength | 82.75 | 62.32 | 63.46 | ||
| Weighted Alpha | +83.21 | +111.75 | +36.37 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 80% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +6.15% since 06/26/26 | +1.39% since 06/26/26 | ||
| Low | 131.63 on 04/01/25 | 230.25 on 06/29/26 | 53.25 on 07/01/26 | ||
| High | 131.98 on 04/01/25 | 246.07 on 07/06/26 | 56.21 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | +2.35% since 06/05/26 | +5.37% since 06/05/26 | ||
| Low | 131.18 on 03/05/25 | 220.74 on 06/18/26 | 50.80 on 06/22/26 | ||
| High | 131.98 on 04/01/25 | 246.07 on 07/06/26 | 56.21 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +30.68% since 04/06/26 | +26.26% since 04/06/26 | ||
| Low | 80.82 on 01/07/25 | 185.46 on 04/07/26 | 43.50 on 05/04/26 | ||
| High | 131.98 on 04/01/25 | 246.07 on 07/06/26 | 56.21 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +46.22% since 01/06/26 | +27.13% since 01/06/26 | ||
| Low | 70.90 on 10/07/24 | 156.95 on 01/08/26 | 39.71 on 03/02/26 | ||
| High | 131.98 on 04/01/25 | 246.07 on 07/06/26 | 56.21 on 07/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 15,294,299 | 14,038,176 | ||
| Shares Outstanding, K | 106,522 | 62,818 | 251,355 | ||
| Annual Sales | 680,850,000 | 4,267,590,000 | 2,320,130,000 | ||
| Annual Net Income | -74,680,000 | -356,150,000 | 782,570,000 | ||
| Last Quarter Sales | 199,220,000 | 1,068,900,000 | 610,810,000 | ||
| Last Quarter Net Income | -16,890,000 | 293,100,000 | 210,470,000 | ||
| 60-Month Beta | 0.46 | 0.32 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 6.34 on 05/05/26 | 0.87 on 05/05/26 | ||
| Earnings Date | 05/06/25 | 08/04/26 | 07/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.99 | 18.05 | ||